These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 35535438)
61. Identification of Prognostic Genes in the Tumor Microenvironment of Hepatocellular Carcinoma. Xiang S; Li J; Shen J; Zhao Y; Wu X; Li M; Yang X; Kaboli PJ; Du F; Zheng Y; Wen Q; Cho CH; Yi T; Xiao Z Front Immunol; 2021; 12():653836. PubMed ID: 33897701 [No Abstract] [Full Text] [Related]
62. Construction of a novel choline metabolism-related signature to predict prognosis, immune landscape, and chemotherapy response in colon adenocarcinoma. Liu C; Liu D; Wang F; Liu Y; Xie J; Xie J; Xie Y Front Immunol; 2022; 13():1038927. PubMed ID: 36451813 [TBL] [Abstract][Full Text] [Related]
63. Integrative transcriptional characterization of cell cycle checkpoint genes promotes clinical management and precision medicine in bladder carcinoma. Shi WW; Guan JZ; Long YP; Song Q; Xiong Q; Qin BY; Ma ZQ; Hu Y; Yang B Front Oncol; 2022; 12():915662. PubMed ID: 36033441 [TBL] [Abstract][Full Text] [Related]
64. Exploration of the Tumor Mutational Burden as a Prognostic Biomarker and Related Hub Gene Identification in Prostate Cancer. Wang L; Yao Y; Xu C; Wang X; Wu D; Hong Z Technol Cancer Res Treat; 2021; 20():15330338211052154. PubMed ID: 34806485 [TBL] [Abstract][Full Text] [Related]
65. Identification of a Novel Nomogram to Predict Progression Based on the Circadian Clock and Insights Into the Tumor Immune Microenvironment in Prostate Cancer. Feng D; Xiong Q; Zhang F; Shi X; Xu H; Wei W; Ai J; Yang L Front Immunol; 2022; 13():777724. PubMed ID: 35154101 [TBL] [Abstract][Full Text] [Related]
66. A New Signature of Sarcoma Based on the Tumor Microenvironment Benefits Prognostic Prediction. Zhang G; Jian A; Zhang Y; Zhang X Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769292 [TBL] [Abstract][Full Text] [Related]
67. A prognostic signature consisting of metabolism-related genes and SLC17A4 serves as a potential biomarker of immunotherapeutic prediction in prostate cancer. Li H; Gu J; Tian Y; Li S; Zhang H; Dai Z; Wang Z; Zhang N; Peng R Front Immunol; 2022; 13():982628. PubMed ID: 36325340 [TBL] [Abstract][Full Text] [Related]
68. Characterization of a Pyroptosis-Related Signature for Prognosis Prediction and Immune Microenvironment Infiltration in Prostate Cancer. Zhang G; Luo Y; Dong W; Zhong W Comput Math Methods Med; 2022; 2022():8233840. PubMed ID: 35516457 [TBL] [Abstract][Full Text] [Related]
69. Immune-Stromal Score Signature: Novel Prognostic Tool of the Tumor Microenvironment in Lung Adenocarcinoma. Qi X; Qi C; Qin B; Kang X; Hu Y; Han W Front Oncol; 2020; 10():541330. PubMed ID: 33072571 [No Abstract] [Full Text] [Related]
70. Comprehensive analysis of tumor mutation burden and immune microenvironment in prostate cancer. Liao J; Ye Y; Xu X Clin Transl Oncol; 2022 Oct; 24(10):1986-1997. PubMed ID: 35732871 [TBL] [Abstract][Full Text] [Related]
71. Bioinformatics profiling utilized a nine immune-related long noncoding RNA signature as a prognostic target for pancreatic cancer. Wei C; Liang Q; Li X; Li H; Liu Y; Huang X; Chen X; Guo Y; Li J J Cell Biochem; 2019 Sep; 120(9):14916-14927. PubMed ID: 31016791 [TBL] [Abstract][Full Text] [Related]
72. Mitochondrial-Related Transcriptome Feature Correlates with Prognosis, Vascular Invasion, Tumor Microenvironment, and Treatment Response in Hepatocellular Carcinoma. Wang Y; Song F; Zhang X; Yang C Oxid Med Cell Longev; 2022; 2022():1592905. PubMed ID: 35535359 [TBL] [Abstract][Full Text] [Related]
73. A four-gene signature in the tumor microenvironment that significantly associates with the prognosis of patients with breast cancer. Wang J; Yang Z; Zhang C; Ouyang J; Zhang G; Wu C Gene; 2020 Nov; 761():145049. PubMed ID: 32791092 [TBL] [Abstract][Full Text] [Related]
74. Comprehensive Analysis of m5C Methylation Regulatory Genes and Tumor Microenvironment in Prostate Cancer. Yu G; Bao J; Zhan M; Wang J; Li X; Gu X; Song S; Yang Q; Liu Y; Wang Z; Xu B Front Immunol; 2022; 13():914577. PubMed ID: 35757739 [TBL] [Abstract][Full Text] [Related]
75. Identification of Prognosis-Related Genes in Bladder Cancer Microenvironment across TCGA Database. Zhao X; Tang Y; Ren H; Lei Y Biomed Res Int; 2020; 2020():9143695. PubMed ID: 33204728 [TBL] [Abstract][Full Text] [Related]
76. Integrative analysis regarding the correlation between collagen-related genes and prostate cancer. Xiao Y; Lai C; Hu J; Mulati Y; Xu X; Luo J; Kong D; Liu C; Xu K BMC Cancer; 2024 Aug; 24(1):1038. PubMed ID: 39174928 [TBL] [Abstract][Full Text] [Related]
77. The Prognosis-Predictive and Immunoregulatory Role of SUMOylation Related Genes: Potential Novel Targets in Prostate Cancer Treatment. Sun JX; An Y; Xiang JC; Xu JZ; Hu J; Wang SG; Xia QD Int J Mol Sci; 2023 Sep; 24(17):. PubMed ID: 37686409 [TBL] [Abstract][Full Text] [Related]
78. Identification of Hypoxia-Related Subtypes, Establishment of Prognostic Models, and Characteristics of Tumor Microenvironment Infiltration in Colon Cancer. Wang C; Tang Y; Ma H; Wei S; Hu X; Zhao L; Wang G Front Genet; 2022; 13():919389. PubMed ID: 35783281 [No Abstract] [Full Text] [Related]
79. Computational construction of TME-related lncRNAs signature for predicting prognosis and immunotherapy response in clear cell renal cell carcinoma. Zhou L; Fang H; Guo F; Yin M; Long H; Weng G J Clin Lab Anal; 2022 Aug; 36(8):e24582. PubMed ID: 35808868 [TBL] [Abstract][Full Text] [Related]
80. Development and Validation of a Prognostic Gene Signature Correlated With M2 Macrophage Infiltration in Esophageal Squamous Cell Carcinoma. Yao J; Duan L; Huang X; Liu J; Fan X; Xiao Z; Yan R; Liu H; An G; Hu B; Ge Y Front Oncol; 2021; 11():769727. PubMed ID: 34926275 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]